









Germline mutations in BRCA1 increase the risk of 
breast and ovarian cancer, but the specific pathways 
driving breast and ovarian cancer development in 
BRCA1 mutants are currently unclear [1]. Several 
studies have demonstrated that BRCA1 is required for 
cellular responses to DNA double strand breaks (DSBs) 
and homologous recombination (HR), although its exact 
role in these processes is unclear. BRCA1 contains an 
N-terminal RING domain and two C-terminal BRCT 
repeats. The BRCA1 RING domain imparts ubiquitin 
ligase activity to BRCA1 through interaction with its 
key binding partner BARD1 [2]. BRCT repeats 
contribute to transcriptional and DNA repair function of 
BRCA1, and cancer associated mutations that disrupt 
BRCT motif impair these activities [3].  
BRCA1 forms at least 3 distinct complexes (BRCA1 A, 
BRCA1 B and BRCA1 C) through association of 
different adaptor proteins with BRCT motif. A-
Complex function has been the subject of considerable 
research interest in the last several years, and is the 
focus of a study by Dever et al. in this issue of Aging 
[4] as well as other recent studies [5, 6]. The A-
Complex consists of BRCA1 in association with the 
ubiquitin interacting motif (UIM) containing protein 
RAP80, the deubiquitinylating (DUB) enzymes 
BRCC36 and BRCC45, MERIT 40 , and the adaptor 
protein Abraxas [7-10]. The A-Complex is thought to 
target BRCA1 to ionising radiation (IR) inducible foci 
through interaction of RAP80 with K63 poly-ubiquitin 
chains at sites of DSBs, in particular on H2AX [7, 11-
13]. This RAP80 recruiting ubiquitinylation is 
performed by the E2 ubiquitin conjugase Ubc13 and the 
E3 ligase RNF8, which are targeted to breaks by MDC1 
[14-16]. The critical role of ubiquitinylation as a 
recruitment signal at DNA damage sites is highlighted 
by the hypersensitivity of Ubc13  and RNF8-deficient 
cells to irradiation [14-17].  
The new study by Dever et al. indicates that disruption 
of the BRCA1 complexes through mutation in BRCT 
motif causes genomic instability due to an increase in 
recombination [4]. Specifically, the authors explored the 
function of the BRCA1 BRCT mutant K1702M, in 
which BRCT mediated phosphoprotein interactions are 
disrupted. They found that expression of K1702M 
caused  radiosensitivity  compared   to  wild-type  comp- 
 
 








lemented BRCA1 deficient cells. Intra-chromosomal 
recombination is commonly assessed using a flow 
cytometry based DR-GFP recombination assay. Dever 
et al. used this method to determine that expression of 
the K1702M mutant was associated with elevated 
recombination compared to wild-type BRCA1, 
indicating that the K1702M mutant disrupts critical 
negative regulation of recombination [4]. It was unclear 
if this increased recombinational activity was due to the 
accumulation of cells in S/G2 [4]. The hyper-
recombination of K1702M cells is in line with two other 
studies which found that transient depletion of non-
BRCA1 members of the A-Complex caused an increase 
in recombination, using a similar DR-GFP approach [5, 
6]. Interestingly, these studies found that siRNA 
depletion of BRCC36, one of the A-Complex 
deubiquitinylating enzymes, increased recombination 
activity to the same extent as RAP80 depletion[5, 6], 
seemingly contradicting earlier studies that reported 
reduced HR by depletion of the components of A-
Complex  [13, 18] and the reason for this lack of 
concordance is unclear. In support of the role of the 
BRCA1 BRCT domain and the A-Complex in negative 
regulation of recombination [4-6], is the finding that a 
balance  between   histone   ubiquitinylation  by  RNF8/ 
Ubc13 and deubiquitinylation by BRCC36/RAP80 is 
critical for maintenance of genomic stability [19]. This 
supports a model where recruitment and subsequent 
deubiquitinylation activity of the A-Complex terminates 
DNA break associated ubiquitinylation. The importance 
of balanced poly-ubiquitin synthesis and removal at the 
break site is highlighted by regulation of FANCD2 [20]. 
Failure to ubiquitinate or deubiquitinate FANCD2 
confers sensitivity to cross-linking agents and impairs 
recombination activity.  
Recent work by Hu et al. showed that the hyper-
recombination activity in RAP80 deficient cells is 
dependent on BRCA1, since double depletion of RAP80 
and BRCA1 suppressed the increased HR observed in 
RAP80 deficient cells [6]. Dever et al. extended on this 
by showing that the hyper-recombination observed in 
BRCT-mutant expressing cells is dependent on BRCA1 
ubiquitin ligase activity [4]. A BRCA1 RING domain 
mutation known to block BRCA1 ubiquitin ligase 
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BRCT mutant K1702M [4]. Given the accumulation of 
K1702M mutant expressing cells in S/G2 phase of the 
cell cycle reported in this study[4], it would be 
interesting to know what effect the I26A/ K1702M 
double mutant has on cell cycle. Taken along with the 
hyper-recombination of BRCC36 depleted cells, these 
results support a model where the A-Complex 
negatively regulates the pro-recombination activity of 
an ubiquitinylation-dependant BRCA1 pathway. 
Some questions raised from this conclusion are: What 
recombination mechanism is the A-Complex 
regulating? What effects does A-Complex disruption 
have on the structure of chromatin surrounding a break 
site? How does A-Complex recruitment and 
deubiquitinylase activity affect recruitment of other 
factors? The mechanism of hyper-recombination in A-
Complex disrupted cells has been addressed by Hu et al. 
[6] and in the Dever et al. [4] study. They found that 
ablation of the BRCA1-Abraxas interaction promotes 
extensive resection, as visualized by an increase in 
single stranded DNA abundance and chromatin 
retention of RPA and RAD51[4, 6]. Elevated binding of 
RPA and RAD51 is indicative of more abundant or 
longer stretches of resected single stranded DNA. In 
fact Hu et al. demonstrated that a single I-SceI induced 
DSB is resected further in cells lacking RAP80, by 




























chromatin-immunoprecipitation (ChIP)-PCR [6]. Dever  
et al. directly measured single stranded DNA by 
detecting BrdU incorporation in non-denaturing 
conditions [4]. Both studies showed that disruption of 
BRCT interactions causes an increase in the abundance 
of single stranded DNA [4, 6]. Thus the hyper-
recombination of A-Complex disrupted cells observed 
in several studies is the result of excessive resection, 
possibly due to loss of A-Complex catalysed 
termination of ubiquitinylation (deubiquitinylation) at 
breaks [19] (Figure 1).  
Taken together these recent studies provide firm 
evidence that the BRCA1 A-Complex fine-tunes the 
repair function of BRCA1 by repressing excessive 
resection in a BRCT dependent manner. Interesting 
areas for further study may include elucidating the role 
of post-translational modifications in A-Complex 
formation and regulation. It would also be interesting to 
examine the interaction profile of BRCT mutants to 
identify mediators of excessive recombination. The 
hyper-recombination observed in BRCC36 depleted 
cells and the decreased recombination observed in Usp1 
(FANCD2 deubiquitinylase) deleted cells highlight a 
central role for different ubiquitin marks on chromatin 
and repair proteins. Identification of A-Complex 
deubiquitinylase targets and downstream effects would 
provide valuable insight into the mechanism of hyper-
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complex Mre11-Rad50-Nbs1 (MRN), which recruits 
and activates the kinase ATM. Activated ATM 
phosphorylates many DNA repair proteins including 
MDC1. ATM phosphorylated MDC1 recruits the 
RNF8-Ubc13 E3 ubiquitin ligase which synthesizes 
K63 linked polyubiquitin on histones H2A and H2AX. 
RAP80 targets the A-Complex to breaks via the 
interactions of its ubiquitin interacting motifs (UIMs) 
with K63 linked polyubiquitin. Ubiquitin-dependent A-
Complex localization to chromatin and subsequent 
deubiquitinylation fine tunes resection, resulting in 
tightly controlled recombination. Failure of A-Complex 
recruitment due to mutation in the BRCT motif, or 
depletion of A-Complex components including 
BRCC36/45 (deubiquitinylases) would alter the 
chromatin ubiquitinylation pattern. Such persistence or 
aberration of chromatin marks would change the 
complement and activity of repair proteins at the break 
site, resulting in de-regulation of repair. We propose 
that deubiquitinylase activity of the A-Complex restricts 
the recruitment and activity of nucleases, so disruption 
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